Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Antigen-specific CD4-positive T cells, commonly known as helper T cells, are a fundamental subset of lymphocytes essential for the coordination of the adaptive immune response (Janeway et al., 2017). These cells are characterized by the expression of the CD4 co-receptor, which enables them to recognize specific peptide antigens presented by Major Histocompatibility Complex class II (MHC II) molecules on professional antigen-presenting cells (StatPearls, 2024). Upon encountering their cognate antigen, these cells undergo clonal expansion and differentiate into various functional subsets, such as Th1, Th2, Th17, and regulatory T cells (Tregs), each defined by a unique cytokine profile that directs the activity of B cells, CD8+ T cells, and innate immune cells (NIH, 2023). In clinical contexts, these cells are primary targets for immunomodulation; for instance, they are suppressed in organ transplantation and autoimmune diseases to prevent tissue damage, while in oncology and vaccinology, strategies aim to enhance their activation to mount effective anti-tumor or anti-pathogen responses (PubMed, 2022). Dysregulation of antigen-specific CD4+ T cells is a hallmark of numerous conditions, including rheumatoid arthritis, multiple sclerosis, and HIV/AIDS, where the loss of these cells leads to profound immunodeficiency (Nature Reviews Immunology, 2021).
Modulation of T-cell receptor signaling, inhibition of costimulatory pathways (e.g., CD80/86 blockade), calcineurin inhibition, and immune checkpoint blockade (PD-1/CTLA-4).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen-specific CD4-positive T cell (CD4+ T cell) (CD4+ T cell).